# About KLOW MD — Independent editorial monograph on the KLOW research blend > KLOW MD is an independent editorial project that publishes summaries of the peer-reviewed research on the KLOW four-peptide blend. We are not a clinic, not a pharmacy, and not a vendor. KLOW MD publishes summaries of the peer-reviewed research literature on the four-peptide KLOW research blend. We are a publisher, not a provider. ## What KLOW MD is KLOW MD is an independent editorial project that publishes summaries of the peer-reviewed research literature on the KLOW four-peptide research blend and its four individual components — KPV, GHK-Cu, BPC-157, and TB-500. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product, and we are not affiliated with any vendor, compounder, or pharmacy. The 'MD' in the domain refers to monograph and desk-reference editorial framing — the way a physician's-desk-reference entry treats a substance — not a representation that the publisher is a licensed physician or operates a medical practice. The work here is editorial commentary on publicly available science. ## Why this site exists KLOW is an unusual subject. It is sold by compounders and research-chemical vendors as a single co-formulation, but it has the literature footprint of four separate compounds — each with its own decades-long paper trail, its own regulatory status, and its own evidence ceiling. No controlled study has tested the four-peptide blend against monotherapy of any single component, against any pairwise or three-peptide subset, or against placebo. Most online writing about KLOW treats the four peptides as one substance and reasons about their combined effects from mechanistic plausibility alone. This site does the opposite. It treats the blend as four monographs in a single shell, surfaces the combination-evidence gap as a primary editorial callout, and presents each component on the same level of restraint the underlying literature uses. ## Editorial standards Every quantitative claim on this site — dose values, half-life numbers, study counts, percentages, gene-expression figures — is sourced to a specific paper, identified by author, journal, year, DOI, and PubMed link. The complete reference list is on the /references page. Inline [N] markers connect every claim in the body text to the underlying citation. We do not write recommended human doses. Where the literature reports an experimental dose, we report it in the third person as the dose used in that specific study. We do not refer to clinics or providers we have no affiliation with. We do not link to vendors, compounders, or supplement marketing pages. We do not use competitor brand names. ## Sourcing methodology We prioritize peer-reviewed primary literature (PubMed, PubMed Central), authoritative regulatory records (FDA bulk-substance lists, WADA prohibited-list entries), and recent systematic and narrative reviews. Where preclinical work dominates a component's evidence base — which is the case for all four KLOW peptides — we are explicit about species, route, and dose, and about the gap between preclinical evidence and human data. Where a component's most-cited 'mechanism' data was generated with a different molecule than the one marketed under the KLOW name (the TB-500-versus-native-Tβ4 distinction is the clearest example), we surface that distinction in the body text rather than blurring it. ## What this site is not We do not sell products. We do not write prescriptions. We do not refer readers to clinics, compounders, telehealth services, or research-chemical vendors. We do not provide individualized medical, scientific, or research advice. We do not interpret the KLOW literature as a treatment recommendation. If you are looking for clinical guidance, this is not the right site for that — please consult a licensed clinician. This site is research-only commentary on publicly available science. The full disclaimer is in the footer of every page. --- An independent editorial monograph on the four-peptide KLOW research blend — not a clinic, not a pharmacy, not a vendor.